Share this article
Share this article
ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced findings of pre-clinical research demonstrating that Ampio s lead drug candidate, Ampion™, provides some of the same anti-inflammatory effects as the steroid dexamethasone but without the significant adverse events associated with steroids. Steroids such as dexamethasone are globally immunosuppressive, to both innate and adaptive immune systems, with effects that are beneficial in the short term and often harmful long-term, said David Bar-Or, M.D., Director and Founder of Ampio Pharmaceuticals.
Novel Drug Regenerates Erectile Nerves Damaged by Prostate Surgery
News provided by
Share this article
Share this article
BRONX, N.Y., April 19, 2021 /PRNewswire/ Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today in
JCI Insight.
These images show neurons cultured in petri dishes and treated with either control (inactive) siRNA (left) or the siRNA drug itself (FL2 siRNA) (right). Neurons treated with the drug regenerate their axons (the thin fibers extending from the neurons central bodies) at a significantly faster rate than control-treated neurons. Scale bar = 0.10 mm.
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021
News provided by
Share this article
LUND, Sweden, April 3, 2021 /PRNewswire/
Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the board of directors has decided to postpone the Annual General Meeting to June 1, 2021, in connection with that Søren Bregenholt takes office as new CEO of Alligator.
In light of the ongoing Covid-19 pandemic, and in order to reduce the risk of infection spreading, the board of directors has decided that the Annual General Meeting will be held only by advance voting (postal vote) in accordance with temporary legislation. This means that the Annual General Meeting will be conducted without the physical presence of shareholders, proxies or external parties and that shareholders exercise of voting rights at the Annual General Meeting can only take place by shareholders voting in advance in the order prescribed.
Linda Lee Tagliamonte, LE receives Top Aesthetician in the Aesthetic Everything® Aesthetic and Cosmetic Medicine Awards 2021
News provided by
Share this article
Share this article
BLUE BELL, Pa., April 3, 2021 /PRNewswire/ Linda Lee Tagliamonte, LE receives Top Aesthetician in the Aesthetic Everything® Aesthetic and Cosmetic Medicine Awards 2021.
ABOUT:
Linda s Lee Tagliamontes journey started with her own battle with acne and acne scars. Beginning in her teenage years and continuing throughout her twenties and thirties, Linda s endless search to find a way to manage her acne, and also remove her acne scars had brought her to numerous doctors and had seen her purchase countless products, all of which claimed to be the magic cure.
4.8 lb and 10lb sizes
8 1950001010 1 (4.8 lb)
8 1950001101 6 (10 lb)
01/2024
09/2021
APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz Brown Sugar Maple Oatmeal Cookie was distributed throughout the Unites States through direct sales, online stores, retails stores and 3
rd party distribution.
No illnesses have been reported to date.
The recall was initiated after it was discovered that product containing milk, eggs, wheat & soy allergens was distributed in packaging that did not reveal the presence of these allergens. Subsequent investigation indicates the problem was caused by an oversight on the label design prior to printing.
Consumers who have purchased APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz Brown Sugar Maple Oatmeal Cookie are urged to return it to the place of purchase for a full refund. Consumers with questions may contact Hi-Tech Pharmaceuticals at 1-888-855-7919 Monday – Friday 9:00 am –7:00 pm EST.